Dr Rebecca Sloan
I am both a qualified actuary and clinical doctor. Prior to joining LCP I was an anaesthetic trainee and junior doctor for four years in the NHS. I have worked at LCP since 2017 where I worked in the pensions actuarial department until 2021 when I joined the Health Analytics team where I specialise in value-based healthcare and women’s health.
I have experience in using a variety of actuarial modelling techniques to help clients manage and understand their risks, and financial forecasting while focusing on their long-term objectives.
Within the Health Analytics team, I use actuarial techniques and my clinical background to help decision makers across the health sector by:
- Developing and modelling innovative reimbursement models, such as outcomes based agreements, to align incentives around patient and population health; and
- Using a range of real world and administrative data to provide insights into the health of the population. Recent partnerships have included the work on “The disease and disparity” report with IPPR and work alongside the RCOG on the “Left for too long” report.
LCP have a practical way of looking at things and cut through the noise on essential issues.
Our latest thinking
Our health analytics approach leverages the increasing availability of data and our cutting-edge modelling approaches to put timely actionable data in the hands of key stakeholders.
We integrate a wealth of health and health-related datasets and develop bespoke interactive visualisations to make it accessible and rapid for clients to glean insights across a range of areas.
Supporting our clients to achieve equitable health outcomes is a golden thread throughout our work. We combine our expertise to translate evidence into change and apply population health analytics to help reduce inequalities in health and health outcomes.
Multimorbidity, living with two or more conditions is one of the biggest challenges facing patients and health systems today. We leverage real world datasets and innovative approaches to generate evidence that identifies patient groups with the greatest unmet needs in a more holistic manner that reflects the drivers of ill health.
We apply scientific rigour to evaluate the economic and clinical value of healthcare interventions using both traditional and innovative perspectives and methods.